Phone:
+1 877 302 8632
Fax:
+1 888 205 9894 (Toll-free)
E-Mail:
orders@antibodies-online.com

CD19 antibody

This anti-CD19 antibody is a Mouse Monoclonal antibody detecting CD19 in FACS. Suitable for Human.
Catalog No. ABIN2223600

Quick Overview for CD19 antibody (ABIN2223600)

Target

See all CD19 Antibodies
CD19 (CD19 Molecule (CD19))

Reactivity

  • 369
  • 175
  • 53
  • 32
  • 19
  • 13
  • 6
  • 5
  • 3
  • 3
  • 3
  • 2
  • 2
  • 2
  • 2
  • 2
  • 2
  • 2
Human

Host

  • 239
  • 146
  • 61
  • 11
  • 4
  • 1
Mouse

Clonality

  • 342
  • 109
  • 6
Monoclonal

Conjugate

  • 151
  • 26
  • 23
  • 22
  • 19
  • 8
  • 8
  • 8
  • 7
  • 6
  • 6
  • 6
  • 5
  • 5
  • 5
  • 5
  • 5
  • 5
  • 4
  • 4
  • 4
  • 4
  • 4
  • 4
  • 4
  • 4
  • 4
  • 4
  • 4
  • 4
  • 4
  • 4
  • 4
  • 4
  • 4
  • 4
  • 3
  • 3
  • 3
  • 3
  • 3
  • 3
  • 3
  • 3
  • 2
  • 2
  • 2
  • 2
  • 2
  • 2
  • 2
This CD19 antibody is un-conjugated

Application

  • 345
  • 139
  • 90
  • 75
  • 70
  • 63
  • 39
  • 20
  • 19
  • 15
  • 14
  • 14
  • 9
  • 5
  • 5
  • 4
  • 3
  • 3
  • 3
  • 3
  • 3
  • 3
  • 2
  • 2
  • 2
  • 1
  • 1
  • 1
  • 1
  • 1
  • 1
  • 1
Flow Cytometry (FACS)

Clone

8H213
  • Cross-Reactivity

    Human

    Cross-Reactivity (Details)

    Calculated cross reactivity: Hu

    Characteristics

    CD19

    Purification

    Purified by Protein G affinity chromatography.

    Immunogen

    Human chronic lymphocytic leukemia lines

    Isotype

    IgG1
  • Application Notes

    Optimal working conditions should be determined by the investigator.

    Restrictions

    For Research Use only
  • Format

    Lyophilized

    Reconstitution

    Reconstitute with 200 μL sterile PBS.

    Buffer

    Supplied as a lyophilized powder from PBS, 5 % trehalose.

    Storage

    -20 °C

    Storage Comment

    -20°C
  • Target

    CD19 (CD19 Molecule (CD19))

    Alternative Name

    CD19

    UniProt

    P15391

    Pathways

    Fc-epsilon Receptor Signaling Pathway, EGFR Signaling Pathway, Neurotrophin Signaling Pathway
You are here:
Chat with us!